Drug resistance associated with antiangiogenesis therapy
Authors:
- 1 October 2009
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 19 (5) , 310-317
Abstract
No abstract availableKeywords
This publication has 139 references indexed in Scilit:
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- Calcification of Multipotent Prostate Tumor EndotheliumCancer Cell, 2008
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and InvasionCancer Cell, 2008
- Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trialThe Lancet, 2007
- Potential therapeutic strategies for lymphatic metastasisMicrovascular Research, 2007
- Tumour vascularization: sprouting angiogenesis and beyondCancer and Metastasis Reviews, 2007
- Genes that Distinguish Physiological and Pathological AngiogenesisCancer Cell, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Predicting benefit from anti-angiogenic agents in malignancyNature Reviews Cancer, 2006
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996